Tag: expects

Categories
World News

Fauci Expects Choice on Utilizing Johnson & Johnson Vaccine Friday

Fauci Expects Decision on Using Johnson & Johnson Vaccine Friday

A decision to resume administration of Johnson & Johnson’s coronavirus vaccine should be made this Friday when a panel of experts advising the Centers for Disease Control and Prevention says Dr. Anthony S. Fauci, the country’s leading infectious disease expert, is to meet.

“I think we will make a decision by then,” said Dr. Fauci on Sunday on CNN’s State of the Union program.

“I don’t want to be one step ahead of the CDC, the FDA and the Advisory Committee,” he added, but said he expected experts to recommend “some kind of warning or restriction” on using the vaccine.

Federal health officials recommended suspending vaccine injections Tuesday while investigating whether this was related to a rare bleeding disorder. All 50 states except Washington, DC and Puerto Rico have stopped giving the vaccine.

The unusual disorder includes blood clots in the brain combined with low levels of platelets, blood cells that typically promote clotting. The combination, which can lead to coagulation and bleeding at the same time, was initially documented in six women between the ages of 18 and 48 who had received the vaccine one to three weeks earlier. One of the women died and another was hospitalized in critical condition.

This pattern has raised questions about whether vaccinations could be resumed in men or in the elderly. However, with women filling more healthcare positions for which vaccination has been prioritized, it is not clear how the problem could affect men as well. Two more cases of the coagulation disorder were identified on Wednesday, including one in a man who received the vaccine in a clinical trial.

Of the 129.5 million people in the United States who received at least one dose of a Covid-19 vaccine, more than seven million have received Johnson & Johnson’s. If there is a link between the vaccine and the coagulation disorder, the risk remains extremely low, according to experts.

“It is an extremely rare occurrence,” said Dr. Fauci on the ABC program “This Week”. The break should give experts time to gather more information and warn doctors about the clotting disorder so they can make more informed treatment decisions, said Dr. Fauci, who appeared on four television news programs on Sunday morning.

European regulators have investigated similar cases of the unusual coagulation disorder in people who received the AstraZeneca vaccine. Some European countries have now stopped giving this vaccine completely, while others have restricted its use in younger people.

Dr. Fauci also expressed frustration that “a worryingly large segment of Republicans” who have criticized many of the coronavirus restrictions have expressed reluctance to vaccinate. “It’s almost paradoxical,” he said. “On the one hand, they want to be released from the restrictions, on the other hand, they don’t want to be vaccinated. It just makes almost no sense. “

Dr. Fauci said he expects all students to be eligible for a vaccination before school starts in the fall, with younger children being eligible by Q1 2022 at the latest.

Categories
Business

Daimler expects intense competitors if Apple, Alibaba enter automobile market

Daimler expects intense competition if Apple, Alibaba enter car market

LONDON – The CEO of Daimler in Germany believes the automaker will face stiff resistance from tech giants like Google, Apple and Alibaba if it decides to launch its own electric vehicles.

While the tech giants haven’t started selling their own cars just yet, reports suggest they could soon launch products that combine hardware and software if the electric vehicle race gets hot.

“There will be intense competition,” Daimler boss Ola Kallenius told CNBC’s Annette Weisbach on Thursday when he was asked if he was concerned about the entry of digital companies into the electric vehicle market.

“When an industry changes, I think it is natural for new players to look at the industry,” he said.

Kallenius said Daimler will “look at what the brand stands for and carry that into the next technological age,” adding that the company will be able to build on its position if it does well.

His comments come when Mercedes Benz, owned by Daimler, launches an electric version of its flagship S-class luxury sedan.

“It’s kind of the beginning of a new era,” said Kallenius, before adding that the new vehicle was very “curious”.

Prices for the luxury sedan will be announced this summer, but Kallenius said Daimler expects to make money on the vehicle from the time it is sold.

He added that the variable cost of vehicles with a large electric battery is higher than that of vehicles with a traditional internal combustion engine.

“Our task in this decade of transformation is on the one hand to reduce variable costs and restore margin parity in all of our segments,” said Kallenius.

Electric vehicle technology is “still in its infancy” and there is “a lot to be done,” he continued. “It will be scaled and we will have technological developments. I am optimistic that we can restore the margins to which we are accustomed.”

Daimler versus Tesla

Daimler’s shares have risen by more than 173% year-on-year in the past 12 months and were quoted on Thursday at 75 euros per share.

“We have positive momentum in our stock,” said Kallenius, adding that this was due to improved financial performance and the company’s “technology strategy for the future.”

However, Daimler’s market capitalization has fallen from around 185 billion euros today in 1998 to just 80 billion euros. Meanwhile, Tesla’s market capitalization has risen to $ 694 billion.

“Now if we look at the total market capitalization of every single auto player in the world, you get an impressive number,” said Kallenius.

He added, “We need to make sure that the distribution of that total market cap is moving more in our favor. We are working on that.”

Like other automobile manufacturers, Daimler’s business was negatively impacted by the global shortage of chips.

“We can currently sell more than we produce,” said Kallenius

Categories
Business

Former Vice President Pence will get pacemaker implanted, expects full restoration

Former Vice President Pence gets pacemaker implanted, expects full recovery

U.S. Vice President Mike Pence announces the Trump administration’s plan to create the U.S. Space Force by 2020 during a speech at the Pentagon on August 9, 2018 in Arlington, Virginia.

Chip Somodevilla | Getty Images

Former Vice President Mike Pence had surgery to have a pacemaker implanted after “symptoms related to a slow heart rate,” his office said Thursday, NBC News reported.

The “routine operation” was successfully carried out on Wednesday, according to Pence’s office, according to which the 61-year-old former vice president is “expected to recover fully and return to normal activity in the coming days.”

The statement stated that Pence’s medical history included a diagnosis of asymptomatic left bundle branch block. He’s had symptoms for the past two weeks and consulted his doctors before undergoing the procedure at the Inova Fairfax Medical campus in Falls Church, Virginia.

“I am grateful for the prompt professionalism and care of the excellent doctors, nurses and staff at Inova Heart and Vascular Institute, including Dr. Brett Atwater and Dr. Behnam Tehrani,” said Pence in the statement.

“I also appreciate the advice of my longtime Indiana doctors, Dr. Michael Busk and Dr. Charles Taliercio of Ascension St. Vincent. My family has been truly blessed by the work of these dedicated health professionals,” said Pence.

Kevin McCarthy, minority chairman of the House of Representatives, R-Calif., Tweeted a message of support to Pence later Thursday.

Pence is widely rumored to be laying the groundwork for a possible 2024 presidential election. However, a candidate’s health and medical history can often have a significant impact on a political campaign.

For example, former President Donald Trump’s state of health underwent an in-depth review in the final months of his re-election bid when he was hospitalized with the coronavirus. Critics had already accused Trump, who is overweight and known to have poor diet, of having misled his medical records.

Campaigns themselves can also be physically and mentally demanding. In 2016, for example, the impotent episode of then-Democratic candidate Hillary Clinton dominated the headlines at an anniversary ceremony on September 11th.

Senator Bernie Sanders, I-Vt., Had a heart attack while running for president in October 2019. He returned to campaigning later that month.

Categories
Business

Okta expects annual income to leap by 30% with addition of latest merchandise

Okta expects annual revenue to jump by 30% with addition of new products

Okta sees great growth ahead as it expands its service offering.

The cybersecurity company announced on Wednesday that it expects 30% revenue growth for the fiscal year as it introduced two new products, one in Privileged Access Management and one in Identity Governance and Administration.

Privileged access is designed to protect data from hacker attacks within a company, while identity management and management is designed to optimize a company’s decision as to what information users can access on their servers.

The addition of these new tools will also increase Okta’s business opportunities by more than 20%, CEO Todd McKinnon told CNBC’s Jim Cramer.

“We have a massive addressable market,” McKinnon said in a Mad Money interview. “With everything moving to the cloud and businesses needing to connect with their customers through digital channels and everyone worrying about security, this massive $ 80 billion TAM (total addressable market) is the foundation for sustainable growth across the world a long period of time. “

Okta offers security tools to authenticate users, e. B. Password permissions and access to online networks.

In terms of privileged access management and identity management and administration, Cramer determined that the company will enter markets dominated by CyberArk and SailPoint Technologies. Okta also works with both companies.

McKinnon suggested the identity governance and privileged access services market opportunity is $ 15 billion.

“There’s enough space for many vendors to strive for. We’re taking it from a very cloud-centric approach,” he said. “We will continue to work with these partners while doing what our customers ask us to do. That covers all use cases of their identity.”

Okta forecasts total sales of up to $ 1.09 billion for the current fiscal year. The company had sales of $ 835.4 million for the previous fiscal year ended January 31.

The growth has steadily slowed down in recent years. Okta posted revenue growth of 42.5% in fiscal 2021, compared to 53.6% in fiscal 2019.

Categories
Business

BorgWarner expects EVs to account for nearly 50% of income by 2030

BorgWarner expects EVs to account for almost 50% of revenue by 2030

The CEO of auto parts supplier BorgWarner told CNBC on Friday that the company hopes almost 50% of its sales will be related to electric vehicles within the next decade.

Electric vehicles currently account for less than 3% of the Michigan-based company’s sales.

“We assume that 30% of the vehicle will be battery-electric in 2030. This is already a bullish assumption. We assume that we will generate 45% of our sales,” said CEO Frederic Lissalde in an interview with Jim Cramer about “Mad Money”.

BorgWarner’s drive to grow its EV business is in line with the moves in the automotive industry. A number of electric vehicle startups have hit public markets in recent months, and established titans like General Motors and Ford have announced aggressive efforts to move away from internal combustion engines.

GM plans to exclusively offer electric vehicles by 2035, the company announced earlier this year, and to become carbon neutral by 2040. In February, nearby rival Ford announced plans to nearly double its EV investments by 2025.

BorgWarner manufactures automatic transmissions and turbochargers, among other things. Both Ford and GM are customers, as are Volkswagen and Stellantis, who make Jeep and Dodge vehicles.

BorgWarner is investing heavily in growing its EV business and plans to spend around $ 8 billion on the effort by 2025, Lissalde told Cramer, “We’re funding this pivot ourselves.”

“It’s going in the direction of electrification, we at BorgWarner think that’s really profound. It is going at different speeds and in different regions, but it is profound. Both for light vehicles and commercial vehicles,” he added.

BorgWarner’s shares rose 4.7% on Friday, trading at $ 45.74 apiece. The stock is up more than 18% since the start of the year and around 83% in the past 12 months.

Categories
Business

VW expects half of U.S. gross sales to be electrical automobiles by 2030

VW expects half of U.S. sales to be electric vehicles by 2030

Volkswagen ID Buzz vehicle.

Aeva

Volkswagen is accelerating its plans for fully electric vehicles in order to become “the world’s most coveted brand for sustainable mobility,” a title that probably already belongs to Tesla.

The German automaker said Friday morning that more than 70% of its Volkswagen brand’s European sales will be electric vehicles by 2030, compared to an earlier target of 35%. In the United States and China, half of all sales are expected to come from electric vehicles by then.

“We are accelerating the pace,” said Ralf Brandstaetter, who runs the Volkswagen brand, in a statement. “In the coming years we will change Volkswagen like never before.” The company also owns Audi, Lamborghini, Porsche, and several other luxury brands. However, Friday’s announcement applies to VW brand vehicles, including Passat and Jetta.

Volkswagen plans to spend around 16 billion euros on investments in future trends such as “electromobility, hybridization and digitization” by 2025. The automaker also plans to make autonomous driving functions generally available by 2030.

Volkswagen is the youngest automaker to accelerate or announce a switch from vehicles with conventional internal combustion engines to fully electric motors. Volvo announced earlier this week that it would not start offering electric vehicles until the end of the decade, while General Motors announced it would become an all-electric automaker by 2035. Stellantis, the product of the merger between Fiat Chrysler and PSA Groupe, plans to have fully electric or hybrid versions of all vehicles in Europe by 2025.

While such goals may seem a long way off, traditionally it takes automakers five to seven years to develop and bring a new vehicle to market. Electric vehicles are expected to shorten this time frame as they require fewer components than traditional gas-powered cars and have some of the same parts that can be used to build them.

The announcements follow investor optimism in EV startups as well as a surge in Tesla shares over the past year that made the California-based company the world’s most valued automaker by market cap.

Government incentives and the tightening of CO2 emissions targets are causing automakers to release electric vehicles more than customers ask of them. According to IHS Markit, electric vehicles accounted for around 3.3% of the 76.5 million vehicles sold worldwide in 2020. The research firm predicts that electric vehicle sales will rise to 12.2 million in 2025, an annual growth of almost 52%.

Categories
Health

Novavax expects FDA clearance as early as Might

Novavax expects FDA clearance as early as May

The Food and Drug Administration could approve Novavax’s Covid-19 vaccine for emergencies as early as May, the company’s CEO Stanley Erck told CNBC on Monday.

Novavax’s Phase 3 trial in the US with 30,000 participants is ongoing, Erck said. The company hopes the FDA will allow it to use data from its UK clinical trial when it files its emergency use application later this year, he added.

The UK health authorities are likely to review the vaccine in April, followed by the FDA “probably a month after,” he said in an interview with CNBC’s “Closing Bell”.

That schedule could be postponed for a month or two while the FDA waits for the U.S. trial dates, he said.

Novavax is among several companies working to develop vaccines against the virus, which on Monday infected more than 114 million people worldwide and killed at least 2.53 million people, according to Johns Hopkins University. Three vaccines – from Pfizer, Moderna, and Johnson & Johnson – have so far been approved for use in the United States.

In late January, Novavax released results of its Phase 3 trial data in the UK, showing that the vaccine was 89.3% overall effective, despite being used against B.1.1.7, the strain first discovered in the UK, and B.1.351 was a little less effective. the tribe first discovered in South Africa.

The company said the vaccine was well tolerated, adding that “serious, serious and medically treated adverse events occurred in low levels and were balanced between vaccine and placebo groups”.

Novavax has signed a contract with the US government to supply 110 million cans. The company could complete those shipments in June or July, Erck said.

If the company’s vaccine is approved in the US, it doesn’t worry about demand, even though three vaccines are already widely available.

“The US has a huge need for vaccines and it’s a big world,” he said, adding the company has commitments for 200 million doses elsewhere.

Categories
Business

Chinese language electrical automobile start-up Li Auto expects to promote fewer than Nio

Chinese electric car start-up Li Auto expects to sell fewer than Nio

A Li Xiang One Hybrid SUV is on display during the 18th Guangzhou International Auto Show in Guangzhou, China on Nov 23, 2020.

Li Zhihao | Visual China Group | Getty Images

BEIJING – Chinese automaker Li Auto, listed on the Nasdaq, is forecasting deliveries in the first quarter that will be below those of its competitors.

Li Auto announced late Thursday that it is expected to deliver between 10,500 and 11,500 cars, or fewer than 4,000 vehicles per month, for the first quarter of the year. Shares fell 9.8% in the New York trading session on a wider market sell-off. The stock lost another 3.75% in over-the-counter trading.

Nio, which competes directly with Li Auto in the high-end SUV market, shipped more than 7,000 units in both December and January. The company will release its latest financial report on Monday.

Xpeng shipped 5,700 cars in December and more than 6,000 in January.

Although the numbers of startups suggest rapid growth, they still pale in comparison to Tesla. Elon Musk’s electric car company shipped nearly half a million vehicles worldwide last year, which is an average of more than 41,000 cars per month.

Despite the New Year holiday in mid-February this year, Li Auto’s poor forecast is worrying, said Tu Le, founder of Beijing-based consulting firm Sino Auto Insights.

He pointed out that the company only has one product compared to the other startups and that it should deliver at least 5,000 to 7,000 vehicles a month to keep up.

Li Auto’s only vehicle, the Li One, is a hybrid electric vehicle equipped with a fuel tank to charge the battery.

Analysts have said the feature makes the Li One attractive to Chinese consumers who are concerned about running out of power without access to a charging station.

Last year, the Li One was one of the top 10 high-end SUVs sold in China, regardless of the fuel type, according to the passenger car association. However, the company announced that January shipments fell from 6,126 the previous month to 5,379 units.

The company reported total revenue of 4.15 billion yuan ($ 635.5 million) for the fourth quarter, compared with 2.51 billion yuan in the previous quarter.

Li Auto expects total sales for the first three months of this year to be in line with the last two quarters, with an expected range of 2.94 to 3.22 billion yuan.

Categories
Business

Indian airline IndiGo expects to achieve pre-Covid capability by end-2021

Indian airline IndiGo expects to reach pre-Covid capacity by end-2021

SINGAPORE – India’s low-cost airline IndiGo may struggle with its international operations, but the division could fully recover by the end of the year, the airline’s chief executive told CNBC this week.

Ronojoy Dutta of IndiGo, operated by InterGlobe Aviation, said the division between domestic and international segments for the airline was a “story of two cities”.

The domestic recovery has been strong, while the overseas recovery has brought “all the challenges of Covid and testing and quarantine,” he told CNBC’s Street Signs Asia on Monday.

The country last week extended a ban on international commercial passenger flights to the end of February. Local trips were allowed to resume in May.

IndiGo is a low cost airline that mainly operates domestic flights and is India’s largest passenger airline.

Aircraft operated by Go Airlines Ltd. and IndiGo, a unit operated by InterGlobe Aviation, will be on display at Terminal 3 of Indira Gandhi International Airport in New Delhi, India on Sunday, June 28, 2020.

T. Narayan | Bloomberg | Getty Images

“We’re only struggling with 28% of our capacity from Covid,” he said of international flights. However, domestic activities have reached 80% of the prepandemic level.

“I think we should reach 100% inland capacity by April at the latest,” Dutta predicted. “Internationally will open more slowly, but by the end of the calendar year 2021 we should also be at the level before Covid internationally.”

This forecast is more optimistic than other airline executives. AirAsia CEO Tony Fernandes told CNBC that passenger capacity is unlikely to hit pre-coronavirus levels by 2023.

Emirates President Tim Clark said in November the airline is aiming for a return to profitability in 2022.

“Growth opportunities”

IndiGos Dutta also sees the airline’s prospects as positive after the end of the coronavirus situation.

“Once the pandemic crisis is behind us, we see many growth opportunities,” he said.

He said India has very little air traffic penetration and there will be “a large amount of pent-up demand” when the economy recovers.

“Is international [an] even brighter picture, “he said, adding that profit margins are higher for international flights.

Dutta said he sees “plenty of room for growth” in traveling to and from countries within a six- to seven-hour flight from India such as Russia, Egypt, Malaysia and China.

“We are very excited about these growth prospects and, as you know, there is a major fleet expansion coming up,” he said. “I just itches to come and see until 2022 [to] continues to grow rapidly. “

– CNBC’s Saheli Roy Choudhury, Dan Murphy and Emma Graham contributed to this report.

Categories
Health

Tilray CEO expects U.S. federal hashish legalization inside two years

Tilray CEO expects U.S. federal cannabis legalization within two years

Brendan Kennedy, CEO of medical cannabis producer Tilray, poses in a greenhouse of the Canadian company’s European production site in Cantanhede on April 24, 2018.

Patricia De Melo Moreira | AFP | Getty Images

Brendan Kennedy, CEO of Canadian cannabis company Tilray, is optimistic that the US will take steps to federally legalize marijuana in the near future, which will shake the industry forever.

“I assume that the pressure from the north and the south will eventually cause the US to implement a federal program here sometime in the next 18 to 24 months,” said Kennedy in an interview on CNBC’s “Squawk on the Street” on Wednesday.

Mexico released regulations on medical cannabis use earlier this month, and Kennedy is confident that Mexico and Canada’s positive stance on marijuana will put more pressure on the US

Tilray announced Tuesday that it has been selected by the country’s National Agency for the Safety of Medicines and Health Products as a supplier of medical cannabis for experiments in France.

The company has been selling its cannabis products in Germany since 2017. With the French program launched in the first quarter, Kennedy is optimistic that other European countries will run medical marijuana programs as well.

“While we look forward to our opportunities in Germany and France, we expect additional opportunities for our European companies in the coming quarters,” said Kennedy in an interview with CNBC.

Tilray has licenses to produce cannabis in Canada and Portugal, where the main cannabis facility is located.